Cardiff Oncology (XE7C) Q3 2024 Earnings Report
DE:XE7C Q3 2024 EPS Results
- Actual EPS
- -EUR 0.22
- Consensus EPS
- -EUR 0.24
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.20
DE:XE7C Q3 2024 Revenue Results
- Actual Revenue
- EUR 147.53K
- Expected Revenue
- EUR 62.59K
- Beat/Miss
- Beat by +EUR 84.94K
- YoY Revenue Growth
- +17.02%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/07/2024
- Time
- After Close
- Conference Call
- Thursday, November 7, 2024
DE:XE7C Upcoming Earnings
Cardiff Oncology's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:XE7C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | -0.1 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.12- | -0.15 | ― | |
| Aug 11, 2026 | 2026 (Q2) | -0.11-0.13 | -0.19 | 33.33% (+0.06) | |
| May 14, 2026 | 2026 (Q1) | -0.12-0.16 | -0.18 | 10.00% (+0.02) | |
| Feb 24, 2026 | 2025 (Q4) | -0.17-0.10 | -0.2 | 50.00% (+0.10) | |
| Nov 06, 2025 | 2025 (Q3) | -0.18-0.15 | -0.22 | 32.00% (+0.07) | |
| Jul 29, 2025 | 2025 (Q2) | -0.17-0.19 | -0.23 | 19.23% (+0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.17-0.18 | -0.2 | 9.09% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -0.22-0.20 | -0.19 | -4.76% (-0.01) | |
| Nov 07, 2024 | 2024 (Q3) | -0.24-0.22 | -0.2 | -13.64% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
